Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels

[1]  M. van Meurs,et al.  Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease. , 2017, JCI insight.

[2]  Jennifer J. Kohler,et al.  Modeled structural basis for the recognition of α2–3‐sialyllactose by soluble Klotho , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  T. Walther,et al.  The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  M. Vervloet,et al.  Shedding of klotho by ADAMs in the kidney. , 2015, American journal of physiology. Renal physiology.

[5]  Han Jun Cho,et al.  Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. , 2015, Journal of the American Society of Nephrology : JASN.

[6]  J. Xie,et al.  Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate. , 2015, Journal of the American Society of Nephrology : JASN.

[7]  H. Ulmer,et al.  FGF23 is associated with disease severity and prognosis in chronic heart failure , 2014, European journal of clinical investigation.

[8]  B. Turk,et al.  Identification of Cleavage Sites Leading to the Shed Form of the Anti-Aging Protein Klotho , 2014, Biochemistry.

[9]  F. Artunc,et al.  Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients , 2014, PloS one.

[10]  J. Pankow,et al.  Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study , 2014, Journal of the American Heart Association.

[11]  A. Go,et al.  Fibroblast growth factor-23 and cardiovascular events in CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[12]  C. Nichols,et al.  Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy , 2013, PloS one.

[13]  Liang-Yi Si,et al.  Klotho Suppresses Cardiomyocyte Apoptosis in Mice with Stress-Induced Cardiac Injury via Downregulation of Endoplasmic Reticulum Stress , 2013, PloS one.

[14]  L. Rasmussen,et al.  Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays. , 2013, Clinical biochemistry.

[15]  M. Wolf,et al.  FGF23 Modifies the Relationship Between Vitamin D and Cardiac Remodeling , 2013, Circulation. Heart failure.

[16]  L. Tavazzi,et al.  Multicenter Prospective Observational Study on Acute and Chronic Heart FailureClinical Perspective , 2013 .

[17]  L. Tavazzi,et al.  Multicenter Prospective Observational Study on Acute and Chronic Heart Failure: One-Year Follow-up Results of IN-HF (Italian Network on Heart Failure) Outcome Registry , 2013, Circulation. Heart failure.

[18]  R. Wüthrich,et al.  Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  T. Walther,et al.  Oncostatin M Induces FGF23 Expression in Cardiomyocytes , 2012 .

[20]  J. Ketelslegers,et al.  C-terminal FGF23 is a strong predictor of survival in systolic heart failure , 2012, Peptides.

[21]  B. Kestenbaum,et al.  Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-living Individuals Chs (cardiovascular Health Study) , 2022 .

[22]  T. Szekeres,et al.  Inorganic phosphate and FGF‐23 predict outcome in stable systolic heart failure , 2012, European journal of clinical investigation.

[23]  M. Wolf,et al.  UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE , 2012, Kidney international.

[24]  K. Dickstein,et al.  Aliskiren, ALTITUDE, and the implications for ATMOSPHERE , 2012, European journal of heart failure.

[25]  K. Yuasa,et al.  Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis , 2012, Clinical and Experimental Nephrology.

[26]  J. Xie,et al.  Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart , 2012, Nature Communications.

[27]  A. Go,et al.  FGF23 induces left ventricular hypertrophy. , 2011, The Journal of clinical investigation.

[28]  L. Schurgers,et al.  The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study , 2010, Annals of Internal Medicine.

[29]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[30]  H. Melhus,et al.  Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. , 2009, Atherosclerosis.

[31]  M. Razzaque,et al.  The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis , 2009, Nature Reviews Endocrinology.

[32]  Thomas J. Wang,et al.  Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease , 2009, Circulation.

[33]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[34]  M. Kuro-o.  Klotho as a regulator of oxidative stress and senescence , 2008, Biological chemistry.

[35]  S. Leeman,et al.  Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 , 2007, Proceedings of the National Academy of Sciences.

[36]  K. Okawa,et al.  Klotho converts canonical FGF receptor into a specific receptor for FGF23 , 2006, Nature.

[37]  K. Rosenblatt,et al.  Regulation of Fibroblast Growth Factor-23 Signaling by Klotho* , 2006, Journal of Biological Chemistry.

[38]  Animesh Nandi,et al.  Suppression of Aging in Mice by the Hormone Klotho , 2005, Science.

[39]  M. Kuro-o,et al.  Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein 1 , 1998, FEBS letters.

[40]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[41]  D. Fliser,et al.  Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. , 2013, Kidney international.

[42]  J. Stevens,et al.  The Atherosclerosis Risk in Communities Study , 2013 .

[43]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[44]  M. Kuro-o,et al.  Klotho deficiency causes vascular calcification in chronic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[45]  H. Jüppner,et al.  Endocrine Regulation of Phosphate Homeostasis , 2009 .